サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421832

周期性発熱症候群市場、シェア、規模、動向、産業分析レポート：適応症別、治療別、最終用途別、地域別、セグメント別予測、2024年～2032年

Periodic Fever Syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication ; By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
周期性発熱症候群市場、シェア、規模、動向、産業分析レポート：適応症別、治療別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2023年12月23日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の周期性発熱症候群市場規模は2032年までに8億8,195万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

この分野の成長は、一般に知られていない疾患に関する知識を高めることに焦点を当てた政府プログラムの増加によって助長されています。研究活動の活発化と迅速な技術的ブレークスルーは、新薬の創出、診断能力の強化、治療法の確立につながっており、これらすべてが市場成長に大きく寄与しています。この分野は、この疾患を治療する新薬の承認から恩恵を受ける可能性が高いです。

FMFは、漿膜や滑膜を含む発熱と炎症を繰り返す、世界でもカナダでも最も一般的な単発性の自己炎症性疾患です。常染色体劣性遺伝し、発症率は中東および地中海の先祖を持つ集団で最も高く、他の民族での有病率は様々です。

クリオピリン関連周期性症候群（CAPS）は、一連の自己炎症性疾患です。クリオピリンをコードするCIASl遺伝子に変異があると、インターロイキンiやその他のサイトカインの活性が亢進し、Toll様受容体またはヌクレオチドオリゴマー化ドメイン蛋白ライゲーションとして知られる細胞内受容体を介して標的細胞を活性化します。

イラリスは、TRAPS、高免疫グロブリンD症候群、家族性地中海熱の生物学的製剤として初めてFDAに承認された唯一の薬剤です。この3つの疾患はすべて、周期性発熱症候群として知られる自己炎症性疾患のまれなカテゴリーに属します。FMFは最も頻度の高い疾患であり、主に東地中海沿岸の血統を持つ人々が罹患します。様々な集団で250人から1,000人に1人が罹患し、その大部分は小児です。

ヒドロキシクロロキンのような一般的に使用される薬剤は、COVID-19対策として需要が大幅に増加しています。COVID-19の予防接種と治療薬の必要性から、バイオ医薬品産業は今後大幅に増加すると思われます。このことは、周期性発熱症候群の市場にも大きな影響を与えると予測されます。最近では、カナキヌマブが周期性発熱症候群、クリオピリン関連周期性症候群、周期性発熱症候群、全身型若年性全身性関節炎の治療薬として認可され、周期性発熱症候群ビジネスの成長を後押しする可能性が高いです。

周期性発熱症候群市場レポートハイライト

コルチコステロイドや非ステロイド性抗炎症薬（NSAIDs）などの経口抗炎症薬は、周期性発熱症候群の治療に使用されるため、予測期間中に大きな市場シェアを占めるとみられます。

北米は、同地域の主要企業の浸透が拡大し、患者のケアとモニタリングが重視されるようになったため、世界の周期性発熱症候群分野の市場リーダーとなっています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の周期性発熱症候群市場に関する洞察

  • 周期性発熱症候群市場- 治療スナップショット
  • 周期性発熱症候群市場力学
    • 促進要因と機会
      • 遺伝子調査の進歩
      • 医療従事者や患者の間での意識の高まり
    • 抑制要因と課題
      • 限られた患者群
  • PESTEL分析
  • 周期性発熱症候群の市場治療動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の周期性発熱症候群市場：適応症別

  • 主な調査結果
  • イントロダクション
  • 高免疫グロブリン血症D症候群（HIDS）
  • 家族性地中海熱（FMF）
  • TNF受容体関連周期性症候群（TRAPS）
  • クリオピリン関連周期症候群
  • その他

第6章 世界の周期性発熱症候群市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 小売薬局

第7章 世界の周期性発熱症候群市場：治療別

  • 主な調査結果
  • イントロダクション
  • 経口抗炎症薬
  • 非ステロイド性抗炎症薬（NSAIDs）
  • 抗TNF療法
  • スタチン
  • その他

第8章 世界の周期性発熱症候群市場：地域別

  • 主な調査結果
  • イントロダクション
    • 周期性発熱症候群市場評価、地域別、2019-2032年
  • 周期性発熱症候群市場-北米
    • 北米：周期性発熱症候群市場、適応症別、2019-2032年
    • 北米：周期性発熱症候群市場、治療別、2019～2032年
    • 北米：周期性発熱症候群市場、最終用途別、2019～2032年
    • 周期性発熱症候群市場-米国
    • 周期性発熱症候群市場- カナダ
  • 周期性発熱症候群市場- 欧州
    • 欧州：周期性発熱症候群市場、適応症別、2019～2032年
    • 欧州：周期性発熱症候群市場、治療別、2019～2032年
    • 欧州：周期性発熱症候群市場、最終用途別、2019～2032年
    • 周期性発熱症候群市場- 英国
    • 周期性発熱症候群市場- フランス
    • 周期性発熱症候群市場- ドイツ
    • 周期性発熱症候群市場- イタリア
    • 周期性発熱症候群市場- スペイン
    • 周期性発熱症候群市場- オランダ
    • 周期性発熱症候群市場- ロシア
  • 周期性発熱症候群市場- アジア太平洋
    • アジア太平洋：周期性発熱症候群市場、適応症別、2019～2032年
    • アジア太平洋：周期性発熱症候群市場、治療別、2019～2032年
    • アジア太平洋：周期性発熱症候群市場、最終用途別、2019～2032年
    • 周期性発熱症候群市場- 中国
    • 周期性発熱症候群市場- インド
    • 周期性発熱症候群市場- マレーシア
    • 周期性発熱症候群市場- 日本
    • 周期性発熱症候群市場- インドネシア
    • 周期性発熱症候群市場- 韓国
  • 周期性発熱症候群市場-中東およびアフリカ
    • 中東およびアフリカ：症状別周期性発熱症候群市場、2019～2032年
    • 中東およびアフリカ：周期性発熱症候群市場、治療別、2019～2032年
    • 中東およびアフリカ：周期性発熱症候群市場、最終用途別、2019～2032年
    • 周期性発熱症候群市場- サウジアラビア
    • 周期性発熱症候群市場- アラブ首長国連邦
    • 周期性発熱症候群市場- イスラエル
    • 周期性発熱症候群市場- 南アフリカ
  • 周期性発熱症候群市場-ラテンアメリカ
    • ラテンアメリカ：周期性発熱症候群市場、適応症別、2019-2032年
    • ラテンアメリカ：周期性発熱症候群市場、治療別、2019-2032年
    • ラテンアメリカ：周期性発熱症候群市場、最終用途別、2019～2032年
    • 周期性発熱症候群市場- メキシコ
    • 周期性発熱症候群市場- ブラジル
    • 周期性発熱症候群市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Merck & Co Inc
  • Novartis AG
  • Simvastatin
  • Swedish Orphan Biovitrum AB
図表

List of Tables

  • Table 1 Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 2 Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 3 Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 4 Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 6 North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 7 North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 8 U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 10 U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 13 Canada: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 14 Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 16 Europe: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 18 UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 19 UK: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 20 France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 21 France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 22 France: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 25 Germany: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 26 Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 28 Italy: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 31 Spain: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 32 Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 34 Netherlands: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 37 Russia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 42 China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 43 China: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 44 India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 45 India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 46 India: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 50 Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 52 Japan: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 56 South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 67 UAE: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 68 Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 70 Israel: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 71 South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 73 South Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 74 Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 76 Latin America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 77 Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 79 Mexico: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 80 Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 82 Brazil: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 83 Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 85 Argentina: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Periodic Fever Syndrome Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-Use
  • Figure 7. Global Periodic Fever Syndrome Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 8. Market by Indication
  • Figure 9. Global Periodic Fever Syndrome Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Treatment
  • Figure 11. Global Periodic Fever Syndrome Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 12. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Periodic Fever Syndrome Market
目次
Product Code: PM4152

The global periodic fever syndrome market size is expected to reach USD 881.95 million by 2032, according to a new study by Polaris Market Research. The report "Periodic fever syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication (Hyper-immunoglobulinemia D syndrome, Familial Mediterranean Fever, TNF Receptor Associated periodic syndrome, Cryopyrin Associated periodic syndrome, Others); By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise of the sector is being aided by a rise in government programs focused on raising public knowledge of uncommon disorders. Increased research activity and quick technical breakthroughs are resulting in the creation of new medications, enhanced diagnostic capabilities, and treatments, all of which contribute significantly to market growth. The sector is likely to benefit from new medication approvals to treat the condition.

FMF is the most prevalent monogenic autoinflammatory illness in the world and in Canada, with repeated, self-limited bouts of fever and inflammation involving serous and synovial membranes. It is inherited in an autosomal recessive manner, and its incidence is highest among groups of Middle Eastern and Mediterranean ancestry, with varying prevalence in other ethnicities.

Cryopyrin-associated periodic syndrome (CAPS) is a series of autoinflammatory illnesses that are connected. Mutations in the CIASl gene, which encodes cryopyrin, induce the enhanced activity of interleukin I and other cytokines, which activate their target cells via an intracellular receptor known as the Toll-like receptor or nucleotide oligomerization domain protein ligation.

Ilaris is the first and only FDA-approved biologic therapy for TRAPS, Hyper immunoglobulin D Syndrome, & Familial Mediterranean Fever. All three disorders are part of a rare category of auto-inflammatory diseases known as Periodic Fever Syndromes. FMF is the most frequent condition, affecting primarily those of Eastern Mediterranean heritage. It affects 1 in 250 to 1 in 1,000 people in various populations, with a majority of them being children.

Commonly used medications, such as hydroxychloroquine, have seen a huge increase in demand for COVID-19 control. Because of the need for vaccinations and treatment medications for COVID-19, the biopharma industry is likely to increase significantly in the future. This, in turn, is projected to have a major influence on the market for periodic fever syndrome. Recently, Canakinumab has been licensed for the treatment of individuals with periodic fever syndrome, cryopyrin-associated periodic syndrome, periodic fever syndrome, and systemic juvenile systemic arthritis which likely boosts the growth of periodic fever syndrome business.

Periodic Fever Syndrome Market Report Highlights

Oral anti-inflammatory medicines such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs), among others, are expected to hold a significant market share over the projection period as these are used to treat periodic fever syndrome.

North America is a market leader in the worldwide periodic fever syndrome sector due to the expanding penetration of the region's key companies and the increased emphasis on patient care and monitoring.

The global players include: Merck & Co Inc, Simvastatin, Swedish Orphan Biovitrum AB, and Novartis AG.

Polaris Market Research has segmented the periodic fever syndrome market report based on indication, treatment, end-use and region:

Periodic Fever Syndrome, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Hyperimmunoglobulinemia D syndrome
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor Associated Periodic Syndrome (TRAPS)
  • Cryopyrin Associated Periodic Syndrome
  • Others

Periodic Fever Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral anti-inflammatory drugs
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

Periodic fever syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Retail Pharmacy

Periodic fever syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Periodic Fever Syndrome Market Insights

  • 4.1. Periodic Fever Syndrome Market - Treatment Snapshot
  • 4.2. Periodic Fever Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Genetic Research
      • 4.2.1.2. Growing awareness among healthcare professionals, patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Patient Pool
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Periodic Fever Syndrome Market Treatment Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Periodic Fever Syndrome Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • 5.3. HyperimmunoGlobulinemia D syndrome (HIDS)
    • 5.3.1. Global Periodic Fever Syndrome Market, by HyperimmunoGlobulinemia D syndrome (HIDS), by Region, 2019-2032 (USD Million)
  • 5.4. Familial Mediterranean Fever (FMF)
    • 5.4.1. Global Periodic Fever Syndrome Market, by Familial Mediterranean Fever (FMF), by Region, 2019-2032 (USD Million)
  • 5.5. TNF Receptor-Associated Periodic Syndrome (TRAPS)
    • 5.5.1. Global Periodic Fever Syndrome Market, by TNF Receptor-Associated Periodic Syndrome (TRAPS), by Region, 2019-2032 (USD Million)
  • 5.6. Cryopyrin-Associated Periodic Syndrome
    • 5.6.1. Global Periodic Fever Syndrome Market, by Cryopyrin-Associated Periodic Syndrome, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Periodic Fever Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Periodic Fever Syndrome Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Periodic Fever Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Periodic Fever Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Periodic Fever Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Oral anti-inflammatory drugs
    • 7.3.1. Global Periodic Fever Syndrome Market, by Oral anti-inflammatory drugs, By Region, 2019-2032 (USD Million)
  • 7.4. Non-steroidal anti-inflammatory drugs (NSAIDs)
    • 7.4.1. Global Periodic Fever Syndrome Market, by Non-steroidal anti-inflammatory drugs (NSAIDs), By Region, 2019-2032 (USD Million)
  • 7.5. Anti-TNF therapy
    • 7.5.1. Global Periodic Fever Syndrome Market, by Anti-TNF therapy, By Region, 2019-2032 (USD Million)
  • 7.6. Statins
    • 7.6.1. Global Periodic Fever Syndrome Market, by Statins, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Periodic Fever Syndrome Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Periodic Fever Syndrome Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Periodic Fever Syndrome Market - North America
    • 8.3.1. North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.3. North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.4. Periodic Fever Syndrome Market - U.S.
      • 8.3.4.1. U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.5. Periodic Fever Syndrome Market - Canada
      • 8.3.5.1. Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.4. Periodic Fever Syndrome Market - Europe
    • 8.4.1. Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.3. Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.4. Periodic Fever Syndrome Market - UK
      • 8.4.4.1. UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.5. Periodic Fever Syndrome Market - France
      • 8.4.5.1. France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.3. France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.6. Periodic Fever Syndrome Market - Germany
      • 8.4.6.1. Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.7. Periodic Fever Syndrome Market - Italy
      • 8.4.7.1. Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.8. Periodic Fever Syndrome Market - Spain
      • 8.4.8.1. Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.9. Periodic Fever Syndrome Market - Netherlands
      • 8.4.9.1. Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.10. Periodic Fever Syndrome Market - Russia
      • 8.4.10.1. Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.5. Periodic Fever Syndrome Market - Asia Pacific
    • 8.5.1. Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.4. Periodic Fever Syndrome Market - China
      • 8.5.4.1. China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.3. China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.5. Periodic Fever Syndrome Market - India
      • 8.5.5.1. India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.3. India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.6. Periodic Fever Syndrome Market - Malaysia
      • 8.5.6.1. Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.7. Periodic Fever Syndrome Market - Japan
      • 8.5.7.1. Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.8. Periodic Fever Syndrome Market - Indonesia
      • 8.5.8.1. Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.9. Periodic Fever Syndrome Market - South Korea
      • 8.5.9.1. South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.6. Periodic Fever Syndrome Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.4. Periodic Fever Syndrome Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.5. Periodic Fever Syndrome Market - UAE
      • 8.6.5.1. UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.6. Periodic Fever Syndrome Market - Israel
      • 8.6.6.1. Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.7. Periodic Fever Syndrome Market - South Africa
      • 8.6.7.1. South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.7. Periodic Fever Syndrome Market - Latin America
    • 8.7.1. Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.4. Periodic Fever Syndrome Market - Mexico
      • 8.7.4.1. Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.5. Periodic Fever Syndrome Market - Brazil
      • 8.7.5.1. Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.6. Periodic Fever Syndrome Market - Argentina
      • 8.7.6.1. Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Merck & Co Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Simvastatin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Swedish Orphan Biovitrum AB
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development